The Roles of Insulin, Glucagon, and Free Fatty Acids in the Regulation of Ketogenesis in Dogs

The roles of basal insulin, glucagon, and free fatty acids in the regulation of ketogenesis were studied in three-day-fasted anesthetized dogs. Four protocols were employed: (1) infusion of somatostatin, resulting in combined insulin and glucagon deficiency, (2) somatostatin and intraportal glucagon replacement (1 ng./kg./min.) to produce insulin deficiency, (3) somatostatin combined with intraportal insulin replacement (350 μU./kg./min.) to produce glucagon deficiency, and (4) saline controls. Simultaneous blood sampling from the femoral artery and portal and hepatic veins allowed determination of hepatic uptake or production of free fatty acids, glycerol, ketone bodies, and glucose. When combined deficiency of insulin and glucagon was produced, no significant effect on hepatic ketone production was noted (108 ± 6 per cent of mean basal), whereas the induction of selective Insulin deficiency (basal glucagon level maintained) resulted in a rise of net hepatic ketone production (185 ± 24 per cent of mean basal, P < 0.01). Isolated glucagon lack (basal insulin maintained) did not alter net hepatic ketone production. To assess the effect of increased substrate supply on ketogenesis, all experiments included a period of acute elevation of free fatty adds (FFA), produced by infusion of Intralipld and heparin. FFA elevation in saline controls caused only a moderate stimulation of ketone production (149 ± 16 per cent of mean basal, P < 0.01) despite a threefold increase in FFA uptake. However, the combination of elevation of FFA and selective insulin deficiency (glucagon maintained) resulted in a greatly increased hepatic ketone production (357 ± 58 per cent of mean basal, P < 0.01 vs. controls), which was also significantly higher than during combined insulin and glucagon deficiency (P < 0.05). Lipolysis, as indicated by arterial glycerol levels, as well as hepatic FFA uptake was not affected by acute suppression of pancreatic hormone levels. The study demonstrated that basal insulin plays an important role in repressing ketogenesis and that basal amounts of glucagon, while ineffective in the presence of insulin, exert a stimulatory effect on ketogenesis when insulin is deficient. Glucagon's stimulatory effect on ketogenesis was due to an effect in the liver rather than to an increase in lipolysis or in hepatic FFA uptake. Increasing FFA supply per se was associated with only limited stimulation of ketogenesis, whereas the combination of insulin deficiency, basal concentrations of glucagon, and increased FFA load produced a synergistic augmentation of hepatic ketone production.

[1]  A. Cherrington,et al.  The Roles of Insulin and Glucagon in the Regulation of Gluconeogenesis in the Postabsorptive Dog , 1977, Diabetes.

[2]  M. Caldwell,et al.  The Effect of Somatostatin on Glucose Uptake and Production by Rat Tissues in Vitro , 1977, Diabetes.

[3]  A. Cherrington,et al.  Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. , 1977, The Journal of clinical investigation.

[4]  Jennings,et al.  The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. , 1976, The Journal of clinical investigation.

[5]  R. Eaton,et al.  Modulation of Fatty Acid Metabolism by Glucagon in Man: IV. Effects of a Physiologic Hormone Infusion in Normal Man , 1976, Diabetes.

[6]  E. Tsalikian,et al.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. , 1976, The Journal of clinical investigation.

[7]  R. Eaton,et al.  Glucagon regulation of plasma ketone body concentration in human diabetes. , 1975, The Journal of clinical investigation.

[8]  R. Unger,et al.  Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs. , 1975, Metabolism: clinical and experimental.

[9]  C. J. Goodner,et al.  Adaptation to fasting in baboon. II. Regulation of lipolysis early and late in fasting. , 1975, The American journal of physiology.

[10]  L. Orci,et al.  Identification of glucagon in the gastrointestinal tract. , 1975, The Journal of clinical investigation.

[11]  J. McGarry,et al.  Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. , 1975, The Journal of clinical investigation.

[12]  E. Tsalikian,et al.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. , 1975, The New England journal of medicine.

[13]  J. Field,et al.  Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs. , 1975, The American journal of physiology.

[14]  C. J. Goodner,et al.  Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. , 1975, The Journal of clinical investigation.

[15]  M. Chou,et al.  Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. , 1975, Endocrinology.

[16]  G. Grodsky,et al.  Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion. , 1975, Endocrinology.

[17]  R. Guillemin,et al.  Inhibition of Pancreatic Glucagon Responses to Arginine by Somatostatin in Normal Man and in Insulin-Dependent Diabetics , 1974, Diabetes.

[18]  W. Ganong,et al.  Effect of synthetic somatotropin release inhibiting factor on the increase in plasma growth hormone elicited by L-dopa in the dog. , 1974, Endocrinology.

[19]  S. Fineberg,et al.  Acute Metabolic Effects of Human Growth Hormone , 1974, Diabetes.

[20]  C. J. Goodner,et al.  Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas , 1974, Science.

[21]  S. B. Lewis,et al.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. , 1974, The Journal of clinical investigation.

[22]  K. Alberti,et al.  Inhibition of insulin secretion by somatostatin. , 1973, Lancet.

[23]  R. Scow,et al.  SITES OF LIPOPROTEIN LIPASE ACTIVITY IN ADIPOSE TISSUE PERFUSED WITH CHYLOMICRONS , 1971, The Journal of cell biology.

[24]  C V Greenway,et al.  Hepatic vascular bed. , 1971, Physiological reviews.

[25]  R. Scow,et al.  Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat. , 1970, The Journal of clinical investigation.

[26]  W. A. Müller,et al.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. , 1970, The New England journal of medicine.

[27]  R. Ho Radiochemical assay of long-chain fatty acids using 63Ni as tracer. , 1970, Analytical biochemistry.

[28]  G. J. Stekelenburg,et al.  A simple gas chromatographic determination of acetone and β-ketobutyric acid in blood serum by means of head space gas sampling , 1970 .

[29]  R. Havel,et al.  Hepatic metabolism of free fatty acids in normal and diabetic dogs. , 1970, The Journal of clinical investigation.

[30]  M. Heimberg,et al.  The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. , 1969, The Journal of biological chemistry.

[31]  C. Park,et al.  Control of gluconeogenesis in liver. IV. Differential effects of fatty acids and glucagon on ketogenesis and gluconeogenesis in the perfused rat liver. , 1969, The Journal of biological chemistry.

[32]  R. Unger,et al.  Pancreatic glucagon secretion in normal and diabetic subjects. , 1969, The American journal of the medical sciences.

[33]  R. Unger,et al.  The role of aminogenic glucagon secretion in blood glucose homeostasis. , 1969, The Journal of clinical investigation.

[34]  P. Felig,et al.  Liver and kidney metabolism during prolonged starvation. , 1969, The Journal of clinical investigation.

[35]  S. Chernick [58] Determination of glycerol in acyl glycerols , 1969 .

[36]  B. Plank,et al.  Arterial levels, cardiac and hepatic arteriovenous differences, extraction coefficients and oxygen extraction ratios of various substrates in normal, and in acute and chronic alloxan-diabetic dogs. , 1968, European journal of biochemistry.

[37]  L. Madison,et al.  Physiologic Effects of Metabolic Fuels on Carbohydrate Metabolism: I. Acute Effect of Elevation of Plasma Free Fatty Acids on Hepatic Glucose Output, Peripheral Glucose Utilization, Serum Insulin, and Plasma Glucagon Levels , 1967, Diabetes.

[38]  D. W. Foster Studies in the ketosis of fasting. , 1967, The Journal of clinical investigation.

[39]  H. Krebs,et al.  The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. , 1967, The Biochemical journal.

[40]  J. Williamson Effects of fatty acids, glucagon and anti-insulin serum on the control of gluconeogenesis and ketogenesis in rat liver. , 1967, Advances in enzyme regulation.

[41]  J. Porath,et al.  Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies , 1966 .

[42]  D. Kipnis,et al.  Hormone-fuel interrelationships during fasting. , 1966, The Journal of clinical investigation.

[43]  P. D. Bewsher,et al.  Ketogenic and lipolytic effects of glucagon on liver. , 1966, Biochemical and biophysical research communications.

[44]  D. Young,et al.  A fluorimetric procedure for the determination of ketone bodies in very small quantities of blood. , 1966, Clinica chimica acta; international journal of clinical chemistry.

[45]  D. Kipnis,et al.  Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. , 1965, The Journal of clinical investigation.

[46]  R. Scow,et al.  Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. , 1965, The Journal of biological chemistry.

[47]  V. Marks,et al.  PROMOTION OF INSULIN SECRETION BY GLUCAGON. , 1965, Lancet.

[48]  K. Zierler,et al.  EFFECT OF VERY SMALL CONCENTRATIONS OF INSULIN ON FOREARM METABOLISM. PERSISTENCE OF ITS ACTION ON POTASSIUM AND FREE FATTY ACIDS WITHOUT ITS EFFECT ON GLUCOSE. , 1964, The Journal of clinical investigation.

[49]  K. Isselbacher,et al.  THE METABOLISM OF GLYCEROL BY INTESTINAL MUCOSA. , 1963, Biochimica et biophysica acta.

[50]  H. Meng,et al.  Source of plasma free fatty acids in dogs receiving fat emulsion and heparin. , 1963 .

[51]  D. Steinberg,et al.  EFFECT OF HORMONES ON LIPOLYSIS AND ESTERIFICATION OF FREE FATTY ACIDS DURING INCUBATION OF ADIPOSE TISSUE IN VITRO. , 1963, Journal of lipid research.

[52]  C. M. Leevy,et al.  Estimation of hepatic blood flow with indocyanine green. , 1962, The Journal of clinical investigation.

[53]  H. Krebs,et al.  Enzymic determination of d(−)-β-hydroxybutyric acid and acetoacetic acid in blood , 1962 .

[54]  V. Dole,et al.  Microdetermination of long-chain fatty acids in plasma and tissues. , 1960, The Journal of biological chemistry.

[55]  E. H. Estes,et al.  Titration of free fatty acids of plasma: a study of current methods and a new modification. , 1960, Journal of lipid research.